Profile: Ambry Genetics provides solutions to clinicians, patients, and researchers with comprehensive DNA diagnostic testing. We offer cystic fibrosis tests, CF Amplified™ and 508 First™, which detect more than 99 percent of the 1500-plus known CF mutations in patients of all ethnicities. We offer a unique menu of pulmonary disease genetic tests including the Ambry test-IPF Telomerase to define the genetics of idiopathic pulmonary fibrosis. We also provide mutation testing for primary ciliary dyskinesia, sequencing for alpha-1-antitrypsin deficiency and pulmonary arterial hypertension, plus research testing of the ADRB2 asthma gene & surfactant proteins A & D.